Resolving the cholesterol controversy: the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease
"This book recounts the science and scientific personalities behind the chain of discoveries upon which the lipid hypothesis of atherosclerosis was built. The narrative covers a period of just under a hundred years, starting with Anitschkow's experiments with cholesterol-fed rabbits in 191...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
London ; Hackensack, NJ
World Scientific Publishing Europe Ltd
[2023]
|
| Schlagworte: | |
| Online-Zugang: | FUBA2 |
| Zusammenfassung: | "This book recounts the science and scientific personalities behind the chain of discoveries upon which the lipid hypothesis of atherosclerosis was built. The narrative covers a period of just under a hundred years, starting with Anitschkow's experiments with cholesterol-fed rabbits in 1913, and recounts the endeavours and achievements of the leading actors in this protracted scientific drama. The cast includes an extraordinarily wide variety of scientific disciplines: pathology, biophysics, epidemiology, nutrition, cardiology, lipidology, genetics; microbiology, pharmacology, and clinical trial design. Most of the scientists believed that cholesterol played a causal role in atherosclerosis and cardiovascular disease but there were some who dissented strongly from this conclusion. The breadth of scientific disciplines involved in proving the lipid hypothesis is matched by the geographical spread of the participants. Anitschkow worked in Russia, Endo discovered the first statin in Japan, their commercial development by Merck took place in the USA and evidence of benefit from lowering cholesterol came from trials conducted in Scandinavia and the UK. The subsequent meta-analysis of these statin trials in 2005 proved the validity of the lipid hypothesis beyond any doubt, and the history of how this all came about and its impact upon health policy and medical practice is recalled here in Resolving the Cholesterol Controversy" |
| Beschreibung: | 1 Online-Ressource (XIV, 232 Seiten) Illustrationen |
| ISBN: | 9781800613980 |
Internformat
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV049386492 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 231027s2023 |||| o||u| ||||||eng d | ||
| 020 | |a 9781800613980 |c eBook |9 9781800613980 | ||
| 035 | |a (OCoLC)1409127100 | ||
| 035 | |a (DE-599)BVBBV049386492 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-578 | ||
| 100 | 1 | |a Thompson, G.R. |d 1932- |e Verfasser |0 (DE-588)1089591322 |4 aut | |
| 245 | 1 | 0 | |a Resolving the cholesterol controversy |b the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease |c Gilbert R. Thompson |
| 264 | 1 | |a London ; Hackensack, NJ |b World Scientific Publishing Europe Ltd |c [2023] | |
| 264 | 4 | |c © 2023 | |
| 300 | |a 1 Online-Ressource (XIV, 232 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 505 | 8 | |a Introduction to the Lipid Hypothesis : the role of cholesterol in atherosclerosis -- Nikolai Anitschkow : The cholesterol-fed rabbit, an animal model of atherosclerosis -- John Gofman and Richard Havel : The discovery that cholesterol is transported by lipoproteins in the blood and their centrifugal analysis -- Thomas Dawber and William Kannel : The Framingham Study and risk factors for coronary heart disease -- Ancel Keys : The Seven Countries study and the role of dietary fat in determining cholesterol levels in populations -- Michael Oliver : Pros and cons of lowering cholesterol -- Donald Fredrickson and Robert Levy : The classification of disorders of lipoprotein metabolism -- John Yudkin : The role of sugar in coronary heart disease -- Sir John McMichael and J. R. Anthony Mitchell : Cardiological opponents of the lipid hypothesis -- Nicolas Myant : Familial Hypercholesterolaemia -- Joseph Goldstein and Michael Brown : Discovery of the LDL receptor -- Daniel Steinberg : The role of oxidised LDL in atherosclerosis -- Kåre Berg : Discovery of Lipoprotein (a) -- Gerd Utermann : Discovery of apoE isoforms and their role in lipid metabolism -- Akira Endo : The discovery of the first statin -- P. Roy Vagelos, Alfred Alberts and Jonathan Tobert : The development of statins for clinical use -- Terje Pedersen, James Shepherd and Sir Rory Collins : The statin trials that -- proved the lipid hypothesis -- Impact of proof of the lipid hypothesis on the science and practice of Medicine -- The future of clinical lipidology | |
| 520 | 3 | |a "This book recounts the science and scientific personalities behind the chain of discoveries upon which the lipid hypothesis of atherosclerosis was built. The narrative covers a period of just under a hundred years, starting with Anitschkow's experiments with cholesterol-fed rabbits in 1913, and recounts the endeavours and achievements of the leading actors in this protracted scientific drama. The cast includes an extraordinarily wide variety of scientific disciplines: pathology, biophysics, epidemiology, nutrition, cardiology, lipidology, genetics; microbiology, pharmacology, and clinical trial design. Most of the scientists believed that cholesterol played a causal role in atherosclerosis and cardiovascular disease but there were some who dissented strongly from this conclusion. The breadth of scientific disciplines involved in proving the lipid hypothesis is matched by the geographical spread of the participants. Anitschkow worked in Russia, Endo discovered the first statin in Japan, their commercial development by Merck took place in the USA and evidence of benefit from lowering cholesterol came from trials conducted in Scandinavia and the UK. The subsequent meta-analysis of these statin trials in 2005 proved the validity of the lipid hypothesis beyond any doubt, and the history of how this all came about and its impact upon health policy and medical practice is recalled here in Resolving the Cholesterol Controversy" | |
| 653 | 0 | |a Cholesterol / Physiological effect / History | |
| 653 | 0 | |a Atherosclerosis / History | |
| 653 | 0 | |a Coronary heart disease / History | |
| 653 | 0 | |a Hypercholesteremia | |
| 653 | 0 | |a Antilipemic agents | |
| 653 | 0 | |a Cholesterol, LDL / history | |
| 653 | 0 | |a Cholesterol, LDL / adverse effects | |
| 653 | 0 | |a Atherosclerosis / history | |
| 653 | 0 | |a Coronary Disease / history | |
| 653 | 0 | |a Hypercholesterolemia | |
| 653 | 0 | |a Hypolipidemic Agents | |
| 653 | 0 | |a Cholestérol / Effets physiologiques / Histoire | |
| 653 | 0 | |a Athérosclérose / Histoire | |
| 653 | 0 | |a Hypercholestérolémie | |
| 653 | 0 | |a Hypolipémiants | |
| 653 | 0 | |a Atherosclerosis | |
| 653 | 0 | |a Cholesterol / Physiological effect | |
| 653 | 0 | |a Coronary heart disease | |
| 653 | 6 | |a History | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 1800613970 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 9781800613973 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034714019 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3641444 |l FUBA2 |p ZDB-4-NLEBK |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804186092485738496 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Thompson, G.R. 1932- |
| author_GND | (DE-588)1089591322 |
| author_facet | Thompson, G.R. 1932- |
| author_role | aut |
| author_sort | Thompson, G.R. 1932- |
| author_variant | g t gt |
| building | Verbundindex |
| bvnumber | BV049386492 |
| collection | ZDB-4-NLEBK |
| contents | Introduction to the Lipid Hypothesis : the role of cholesterol in atherosclerosis -- Nikolai Anitschkow : The cholesterol-fed rabbit, an animal model of atherosclerosis -- John Gofman and Richard Havel : The discovery that cholesterol is transported by lipoproteins in the blood and their centrifugal analysis -- Thomas Dawber and William Kannel : The Framingham Study and risk factors for coronary heart disease -- Ancel Keys : The Seven Countries study and the role of dietary fat in determining cholesterol levels in populations -- Michael Oliver : Pros and cons of lowering cholesterol -- Donald Fredrickson and Robert Levy : The classification of disorders of lipoprotein metabolism -- John Yudkin : The role of sugar in coronary heart disease -- Sir John McMichael and J. R. Anthony Mitchell : Cardiological opponents of the lipid hypothesis -- Nicolas Myant : Familial Hypercholesterolaemia -- Joseph Goldstein and Michael Brown : Discovery of the LDL receptor -- Daniel Steinberg : The role of oxidised LDL in atherosclerosis -- Kåre Berg : Discovery of Lipoprotein (a) -- Gerd Utermann : Discovery of apoE isoforms and their role in lipid metabolism -- Akira Endo : The discovery of the first statin -- P. Roy Vagelos, Alfred Alberts and Jonathan Tobert : The development of statins for clinical use -- Terje Pedersen, James Shepherd and Sir Rory Collins : The statin trials that -- proved the lipid hypothesis -- Impact of proof of the lipid hypothesis on the science and practice of Medicine -- The future of clinical lipidology |
| ctrlnum | (OCoLC)1409127100 (DE-599)BVBBV049386492 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05104nmm a2200565 c 4500</leader><controlfield tag="001">BV049386492</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">231027s2023 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781800613980</subfield><subfield code="c">eBook</subfield><subfield code="9">9781800613980</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1409127100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049386492</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Thompson, G.R.</subfield><subfield code="d">1932-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1089591322</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Resolving the cholesterol controversy</subfield><subfield code="b">the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease</subfield><subfield code="c">Gilbert R. Thompson</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London ; Hackensack, NJ</subfield><subfield code="b">World Scientific Publishing Europe Ltd</subfield><subfield code="c">[2023]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 232 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Introduction to the Lipid Hypothesis : the role of cholesterol in atherosclerosis -- Nikolai Anitschkow : The cholesterol-fed rabbit, an animal model of atherosclerosis -- John Gofman and Richard Havel : The discovery that cholesterol is transported by lipoproteins in the blood and their centrifugal analysis -- Thomas Dawber and William Kannel : The Framingham Study and risk factors for coronary heart disease -- Ancel Keys : The Seven Countries study and the role of dietary fat in determining cholesterol levels in populations -- Michael Oliver : Pros and cons of lowering cholesterol -- Donald Fredrickson and Robert Levy : The classification of disorders of lipoprotein metabolism -- John Yudkin : The role of sugar in coronary heart disease -- Sir John McMichael and J. R. Anthony Mitchell : Cardiological opponents of the lipid hypothesis -- Nicolas Myant : Familial Hypercholesterolaemia -- Joseph Goldstein and Michael Brown : Discovery of the LDL receptor -- Daniel Steinberg : The role of oxidised LDL in atherosclerosis -- Kåre Berg : Discovery of Lipoprotein (a) -- Gerd Utermann : Discovery of apoE isoforms and their role in lipid metabolism -- Akira Endo : The discovery of the first statin -- P. Roy Vagelos, Alfred Alberts and Jonathan Tobert : The development of statins for clinical use -- Terje Pedersen, James Shepherd and Sir Rory Collins : The statin trials that -- proved the lipid hypothesis -- Impact of proof of the lipid hypothesis on the science and practice of Medicine -- The future of clinical lipidology</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"This book recounts the science and scientific personalities behind the chain of discoveries upon which the lipid hypothesis of atherosclerosis was built. The narrative covers a period of just under a hundred years, starting with Anitschkow's experiments with cholesterol-fed rabbits in 1913, and recounts the endeavours and achievements of the leading actors in this protracted scientific drama. The cast includes an extraordinarily wide variety of scientific disciplines: pathology, biophysics, epidemiology, nutrition, cardiology, lipidology, genetics; microbiology, pharmacology, and clinical trial design. Most of the scientists believed that cholesterol played a causal role in atherosclerosis and cardiovascular disease but there were some who dissented strongly from this conclusion. The breadth of scientific disciplines involved in proving the lipid hypothesis is matched by the geographical spread of the participants. Anitschkow worked in Russia, Endo discovered the first statin in Japan, their commercial development by Merck took place in the USA and evidence of benefit from lowering cholesterol came from trials conducted in Scandinavia and the UK. The subsequent meta-analysis of these statin trials in 2005 proved the validity of the lipid hypothesis beyond any doubt, and the history of how this all came about and its impact upon health policy and medical practice is recalled here in Resolving the Cholesterol Controversy"</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Cholesterol / Physiological effect / History</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Atherosclerosis / History</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Coronary heart disease / History</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Hypercholesteremia</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Antilipemic agents</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Cholesterol, LDL / history</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Cholesterol, LDL / adverse effects</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Atherosclerosis / history</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Coronary Disease / history</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Hypercholesterolemia</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Hypolipidemic Agents</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Cholestérol / Effets physiologiques / Histoire</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Athérosclérose / Histoire</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Hypercholestérolémie</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Hypolipémiants</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Atherosclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Cholesterol / Physiological effect</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Coronary heart disease</subfield></datafield><datafield tag="653" ind1=" " ind2="6"><subfield code="a">History</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">1800613970</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">9781800613973</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034714019</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3641444</subfield><subfield code="l">FUBA2</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV049386492 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T23:00:16Z |
| indexdate | 2024-07-10T10:05:38Z |
| institution | BVB |
| isbn | 9781800613980 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034714019 |
| oclc_num | 1409127100 |
| open_access_boolean | |
| owner | DE-578 |
| owner_facet | DE-578 |
| physical | 1 Online-Ressource (XIV, 232 Seiten) Illustrationen |
| psigel | ZDB-4-NLEBK |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | World Scientific Publishing Europe Ltd |
| record_format | marc |
| spelling | Thompson, G.R. 1932- Verfasser (DE-588)1089591322 aut Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease Gilbert R. Thompson London ; Hackensack, NJ World Scientific Publishing Europe Ltd [2023] © 2023 1 Online-Ressource (XIV, 232 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier Introduction to the Lipid Hypothesis : the role of cholesterol in atherosclerosis -- Nikolai Anitschkow : The cholesterol-fed rabbit, an animal model of atherosclerosis -- John Gofman and Richard Havel : The discovery that cholesterol is transported by lipoproteins in the blood and their centrifugal analysis -- Thomas Dawber and William Kannel : The Framingham Study and risk factors for coronary heart disease -- Ancel Keys : The Seven Countries study and the role of dietary fat in determining cholesterol levels in populations -- Michael Oliver : Pros and cons of lowering cholesterol -- Donald Fredrickson and Robert Levy : The classification of disorders of lipoprotein metabolism -- John Yudkin : The role of sugar in coronary heart disease -- Sir John McMichael and J. R. Anthony Mitchell : Cardiological opponents of the lipid hypothesis -- Nicolas Myant : Familial Hypercholesterolaemia -- Joseph Goldstein and Michael Brown : Discovery of the LDL receptor -- Daniel Steinberg : The role of oxidised LDL in atherosclerosis -- Kåre Berg : Discovery of Lipoprotein (a) -- Gerd Utermann : Discovery of apoE isoforms and their role in lipid metabolism -- Akira Endo : The discovery of the first statin -- P. Roy Vagelos, Alfred Alberts and Jonathan Tobert : The development of statins for clinical use -- Terje Pedersen, James Shepherd and Sir Rory Collins : The statin trials that -- proved the lipid hypothesis -- Impact of proof of the lipid hypothesis on the science and practice of Medicine -- The future of clinical lipidology "This book recounts the science and scientific personalities behind the chain of discoveries upon which the lipid hypothesis of atherosclerosis was built. The narrative covers a period of just under a hundred years, starting with Anitschkow's experiments with cholesterol-fed rabbits in 1913, and recounts the endeavours and achievements of the leading actors in this protracted scientific drama. The cast includes an extraordinarily wide variety of scientific disciplines: pathology, biophysics, epidemiology, nutrition, cardiology, lipidology, genetics; microbiology, pharmacology, and clinical trial design. Most of the scientists believed that cholesterol played a causal role in atherosclerosis and cardiovascular disease but there were some who dissented strongly from this conclusion. The breadth of scientific disciplines involved in proving the lipid hypothesis is matched by the geographical spread of the participants. Anitschkow worked in Russia, Endo discovered the first statin in Japan, their commercial development by Merck took place in the USA and evidence of benefit from lowering cholesterol came from trials conducted in Scandinavia and the UK. The subsequent meta-analysis of these statin trials in 2005 proved the validity of the lipid hypothesis beyond any doubt, and the history of how this all came about and its impact upon health policy and medical practice is recalled here in Resolving the Cholesterol Controversy" Cholesterol / Physiological effect / History Atherosclerosis / History Coronary heart disease / History Hypercholesteremia Antilipemic agents Cholesterol, LDL / history Cholesterol, LDL / adverse effects Atherosclerosis / history Coronary Disease / history Hypercholesterolemia Hypolipidemic Agents Cholestérol / Effets physiologiques / Histoire Athérosclérose / Histoire Hypercholestérolémie Hypolipémiants Atherosclerosis Cholesterol / Physiological effect Coronary heart disease History Erscheint auch als Druck-Ausgabe, Hardcover 1800613970 Erscheint auch als Druck-Ausgabe, Hardcover 9781800613973 |
| spellingShingle | Thompson, G.R. 1932- Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease Introduction to the Lipid Hypothesis : the role of cholesterol in atherosclerosis -- Nikolai Anitschkow : The cholesterol-fed rabbit, an animal model of atherosclerosis -- John Gofman and Richard Havel : The discovery that cholesterol is transported by lipoproteins in the blood and their centrifugal analysis -- Thomas Dawber and William Kannel : The Framingham Study and risk factors for coronary heart disease -- Ancel Keys : The Seven Countries study and the role of dietary fat in determining cholesterol levels in populations -- Michael Oliver : Pros and cons of lowering cholesterol -- Donald Fredrickson and Robert Levy : The classification of disorders of lipoprotein metabolism -- John Yudkin : The role of sugar in coronary heart disease -- Sir John McMichael and J. R. Anthony Mitchell : Cardiological opponents of the lipid hypothesis -- Nicolas Myant : Familial Hypercholesterolaemia -- Joseph Goldstein and Michael Brown : Discovery of the LDL receptor -- Daniel Steinberg : The role of oxidised LDL in atherosclerosis -- Kåre Berg : Discovery of Lipoprotein (a) -- Gerd Utermann : Discovery of apoE isoforms and their role in lipid metabolism -- Akira Endo : The discovery of the first statin -- P. Roy Vagelos, Alfred Alberts and Jonathan Tobert : The development of statins for clinical use -- Terje Pedersen, James Shepherd and Sir Rory Collins : The statin trials that -- proved the lipid hypothesis -- Impact of proof of the lipid hypothesis on the science and practice of Medicine -- The future of clinical lipidology |
| title | Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease |
| title_auth | Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease |
| title_exact_search | Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease |
| title_exact_search_txtP | Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease |
| title_full | Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease Gilbert R. Thompson |
| title_fullStr | Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease Gilbert R. Thompson |
| title_full_unstemmed | Resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease Gilbert R. Thompson |
| title_short | Resolving the cholesterol controversy |
| title_sort | resolving the cholesterol controversy the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease |
| title_sub | the scientists who proved the lipid hypothesis of causation of atherosclerosis and coronary heart disease |
| work_keys_str_mv | AT thompsongr resolvingthecholesterolcontroversythescientistswhoprovedthelipidhypothesisofcausationofatherosclerosisandcoronaryheartdisease |